NAC and Endometriosis: Understanding the Potential Benefits of Oral and IV Therapy

For people living with endometriosis, treatment often involves much more than addressing the lesions themselves. Chronic inflammation, oxidative stress, pain signaling, immune dysfunction, and the effects of repeated surgery or medication can all influence how a patient feels and functions.

One therapy receiving increasing attention is N-acetylcysteine (NAC)—a compound best known for its antioxidant properties and its ability to support the body's production of glutathione, one of our most important natural antioxidant systems.

NAC is not a cure for endometriosis, and it should not be considered a replacement for appropriate medical, hormonal, or surgical treatment. However, emerging research suggests that NAC may have a role as an adjunctive, non-hormonal therapy for selected patients with endometriosis.

What Is NAC?

N-acetylcysteine, or NAC, is a derivative of the amino acid cysteine. It has been used medically for decades, most notably as an intravenous treatment for acetaminophen toxicity and as a mucolytic medication.

One of NAC's most important biological functions is providing cysteine needed to replenish glutathione.

Why does this matter in endometriosis?

Endometriosis is increasingly understood as more than simply tissue growing outside the uterus. The disease involves a complex interaction among inflammation, oxidative stress, immune signaling, estrogen-dependent activity, cellular proliferation, pain pathways, and tissue remodeling.

NAC may influence several of these processes through its antioxidant and redox-modulating effects. A 2026 systematic review of NAC and endometriosis found biological evidence involving oxidative stress, inflammatory signaling, cellular proliferation, COX-2, TNF-α, matrix metalloproteinases and other pathways relevant to endometriosis.

Why Oxidative Stress Matters in Endometriosis

Our cells continuously produce molecules known as reactive oxygen species (ROS). Under normal circumstances, the body's antioxidant systems keep these molecules in balance.

When ROS production exceeds antioxidant defenses, oxidative stress occurs.

Oxidative stress has been implicated in the inflammatory environment associated with endometriosis. This creates an interesting therapeutic question:

Can improving the body's antioxidant and redox balance help reduce some of the biological processes contributing to endometriosis symptoms and lesion activity?

This is one reason researchers have become interested in NAC.

NAC can help replenish glutathione while also participating in redox regulation and influencing inflammatory signaling. Recent research describes NAC as a potential adjunctive therapy that warrants further investigation in endometriosis.

What Does the Research Show?

Clinical research is still limited, but some results are encouraging.

In a prospective study involving 120 patients with endometriosis, participants received oral NAC for three months. Researchers reported significant improvements in:

• Dysmenorrhea, or painful periods

• Dyspareunia, or pain with intercourse

• Chronic pelvic pain

• NSAID use

• Endometrioma size

• CA-125 levels

The study also reported encouraging pregnancy outcomes among participants who desired pregnancy, although fertility findings require further confirmation.

A larger 2026 systematic review examining 22 clinical and preclinical studies concluded that NAC has a biologically plausible role in endometriosis. In non-postoperative clinical settings, NAC was associated with improvements in pain, reduced NSAID use, and shrinkage or stabilization of endometriomas.

However, the authors emphasized an important limitation: the clinical evidence remains heterogeneous and methodologically limited. The only postoperative randomized comparison included in the review did not demonstrate additional benefit from NAC when added to continuous oral contraceptive therapy.

In other words, NAC is promising—but we should not describe it as a proven treatment for endometriosis.

Oral NAC vs. IV NAC: What's the Difference?

NAC can be administered orally or intravenously, but these routes should not be viewed as interchangeable.

Oral NAC

Oral NAC is convenient, accessible, and is the form that has been most directly studied clinically in women with endometriosis.

One frequently studied endometriosis protocol used 600 mg three times daily for three consecutive days each week for three months. Importantly, this is a research protocol—not a universal recommendation for every patient.

Oral NAC undergoes substantial intestinal and liver metabolism. The bioavailability of intact oral NAC is relatively low—generally reported at less than 10%—although its metabolites and contribution to cysteine and glutathione metabolism remain biologically important.

Potential advantages of oral NAC include convenience, lower cost, suitability for longer-term use, and the fact that the current human endometriosis evidence primarily involves oral therapy.

Its disadvantages include gastrointestinal side effects in some patients, adherence to repeated dosing, and substantially lower systemic exposure to intact NAC compared with IV administration.

IV NAC

Intravenous NAC bypasses intestinal absorption and first-pass metabolism and can therefore achieve much higher and more rapid blood concentrations than oral administration.

That pharmacologic difference makes IV NAC interesting when considering antioxidant and glutathione-support strategies.

But there is an important distinction:

Higher blood concentrations do not automatically mean better treatment of endometriosis.

At present, there is substantially more direct clinical evidence for oral NAC in endometriosis than for IV NAC specifically as an endometriosis therapy. The fact that IV administration produces greater systemic exposure should not be interpreted as proof that IV NAC shrinks lesions, improves fertility, or controls endometriosis pain better than oral NAC.

IV vs. Oral NAC at a Glance

Does That Mean IV NAC Is Better?

Not necessarily.

This is one of the most important points for patients to understand.

IV NAC provides greater and faster systemic exposure, but oral NAC currently has the stronger direct evidence base in endometriosis.

The appropriate question therefore isn't simply:

"Which one is stronger?"

It is:

"What are we trying to accomplish for this particular patient?"

For some patients, a clinician may consider oral NAC as part of a longer-term integrative strategy. In other situations, IV therapy may be considered for specific clinical goals where intravenous administration is medically appropriate.

The two approaches may have different roles rather than one automatically replacing the other.

Where Does NAC Fit Into Endometriosis Care?

Endometriosis generally requires a multimodal treatment strategy.

Depending upon the individual patient, care may include expert evaluation, excision surgery when appropriate, hormonal management, pelvic-floor rehabilitation, nutrition, pain management, gastrointestinal support, physical rehabilitation, sleep and stress management, and other individualized interventions.

NAC may potentially complement this approach by targeting a different part of the picture: oxidative and inflammatory biology.

This is particularly interesting because NAC is non-hormonal.

For patients who cannot tolerate hormonal therapy, are attempting pregnancy, or are looking for additional supportive strategies, the possibility of a non-hormonal adjunct naturally attracts interest. However, these situations require individualized medical guidance, particularly around fertility treatment, surgery, pregnancy, medications, and other health conditions.

NAC Before and After Endometriosis Surgery

NAC also raises interesting questions in the perioperative setting.

Before surgery, optimizing nutrition, hydration, antioxidant capacity and overall health may be components of a broader pre-operative wellness strategy.

After surgery, the goals shift toward healing, recovery, inflammation management, restoration of function and development of a sustainable long-term management plan.

However, patients should not assume that taking NAC after excision has been proven to prevent recurrence. In fact, the 2026 systematic review found that the available postoperative randomized comparison did not demonstrate an additional benefit for recurrence or pain when NAC was added to continuous oral contraceptive treatment.

That distinction is important when separating promising biology from established clinical outcomes.

The Bigger Picture: Treating the Patient, Not Just the Lesions

Perhaps the most useful way to think about NAC is not as another "endometriosis treatment," but as one possible component of a broader care strategy.

Endometriosis can affect far more than reproductive organs. Pain, inflammation, gastrointestinal symptoms, pelvic-floor dysfunction, fatigue, sleep, nutrition, nervous-system sensitization and quality of life can become interconnected.

Effective long-term care therefore often requires asking more than:

"How do we remove the endometriosis?"

We should also ask:

"How do we help this patient's body recover, function and remain as healthy as possible?"

NAC represents one intriguing area of that evolving conversation.

The Bottom Line

N-acetylcysteine is an established medication and antioxidant precursor with biological properties that make it particularly interesting in endometriosis.

Current research suggests that NAC may influence oxidative stress, glutathione availability, inflammatory signaling, cellular proliferation and other pathways relevant to endometriosis. Human studies of oral NAC have reported improvements in pain, NSAID use and endometrioma size, but the evidence is not yet strong enough to consider NAC a stand-alone or proven disease-modifying therapy.

Oral NAC currently has considerably more direct clinical evidence for endometriosis. IV NAC provides much greater systemic exposure, but there is not yet good evidence demonstrating that IV NAC produces superior endometriosis outcomes.

That makes NA

C best viewed as a potential adjunct within individualized endometriosis care—not a replacement for appropriate medical evaluation, surgery when indicated, hormonal treatment, rehabilitation, or other established therapies.

As research continues, NAC may ultimately help us better understand an important principle of comprehensive endometriosis care: treating the disease matters, but so does addressing the biological environment in which the disease exists.

Medical Disclaimer: This article is intended for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. NAC may interact with medications and may not be appropriate for every patient. Oral supplements and intravenous NAC should be used under the guidance of an appropriately licensed healthcare professional.